A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

June 5, 2025

Study Completion Date

June 5, 2025

Conditions

EndometriosisUterine FibroidsAssisted Reproduction

Interventions

DRUG

SHR7280 Tablets

SHR7280 tablets.

Trial Locations (1)

Zhongnan hospital of Wuhan University, Wuhan

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY